Where do Sana Biotechnology's ratios come from?

Every ratio is computed from Sana Biotechnology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Sana Biotechnology SANA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-147.4%-76.0pp	-118.7%-19.5pp	-96.1%-3.2pp	-109.1%-38.6pp	-71.4%+5.4pp
Return on assets	-59.1%-22.1pp	-53.2%-3.2pp	-47.1%+4.2pp	-51.4%-14.5pp	-37%+6.2pp
Return on invested capital	-157.6%-74.0pp	-130%-15.3pp	-110.1%+2.3pp	-117.4%-32.7pp	-83.6%+9.5pp
Liquidity
Current ratio	1.3×-2.1×	1.9×-1.7×	4.6×+0.1×	2.5×-2.7×	3.4×-2.7×
Quick ratio	1.3×-2.1×	1.9×-1.7×	4.6×+0.1×	2.5×-2.7×	3.4×-2.7×
Cash ratio	1×-1.9×	0.9×-1.9×	2.9×+0.2×	2.1×-0.5×	2.9×-0.4×
Leverage
Debt-to-equity	0.6×+0.2×	0.5×+0.1×	0.4×+0.1×	0.7×+0.4×	0.4×+0.2×
Debt-to-assets	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×+0.1×	0.2×0.0×
Interest coverage	-65.2×-40.0×	-65.1×-39.0×	-56.8×-29.7×	-44.5×-23.1×	-25.2×+3.9×
Per Share
Book value per share	$0.43-51.1%	$0.64-41.4%	$0.75-39.6%	$0.51-64.5%	$0.88-49.0%
Valuation
Market capitalization	$907.23M+54.1%	$1.08B+198%	$913.24M-6.4%	$669.9M-43.5%	$378.04M-80.8%
Enterprise value	$898.76M+53.9%	$1.09B+230%	$892.12M-5.5%	$684.12M-40.5%	$373.22M-80.4%
Price / book	7.6×+4.8×	6.7×+5.3×	4.7×+1.3×	5.5×+2.0×	1.8×-3.5×
Free cash flow yield	-14.7%+23.3pp	-13.4%+57.2pp	-17.4%+10.8pp	-27.7%-3.6pp	-59.2%-45.4pp
Earnings yield	-26.7%+8.8pp	-22.5%+50.8pp	-25.7%+5.7pp	-37.6%-17.0pp	-55.2%-39.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Sana Biotechnology's ratios come from?: Every ratio is computed from Sana Biotechnology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.